Puzo Michael J Eli Lilly & CO Transaction History

Puzo Michael J

$375 Million
Q3 2024

A detailed history of Puzo Michael J transactions in Eli Lilly & CO stock. As of the latest transaction made, Puzo Michael J holds 780 shares of LLY stock, worth $583,447. This represents 0.18% of its overall portfolio holdings.

Number of Shares

780

Previous 950 17.89%

Holding current value

$583,447

Previous $860,000 19.65%

% of portfolio

0.18%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $131,263 - $163,203	-170 Reduced 17.89%	780 $691,000
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $108,730 - $136,356	-150 Reduced 13.64%	950 $860,000
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $103,635 - $138,649	-175 Reduced 13.73%	1,100 $855,000
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $105,038 - $123,826	-200 Reduced 13.56%	1,275 $743,000
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $184,747 - $254,702	-425 Reduced 22.37%	1,475 $792,000
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $113,990 - $152,418	-325 Reduced 14.61%	1,900 $891,000
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $100,954 - $118,566	-325 Reduced 12.75%	2,225 $764,000
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $55,746 - $65,454	-200 Reduced 7.27%	2,550 $827,000
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $36,425 - $45,204	-162 Reduced 5.56%	2,750 $760,000
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $49,860 - $61,359	-225 Reduced 7.17%	2,912 $673,000
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $18,055 - $23,354	-100 Reduced 3.09%	3,137 $720,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $16,432 - $21,272	-100 Reduced 3.0%	3,237 $605,000
Q3 2020 Oct 28, 2020	SELL	$146.22 - $169.13 $7,311 - $8,456	-50 Reduced 1.48%	3,337 $494,000
Q2 2020 Jul 28, 2020	SELL	$136.42 - $164.18 $13,641 - $16,418	-100 Reduced 2.87%	3,387 $556,000
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $2,669 - $2,904	-25 Reduced 0.71%	3,487 $390,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $11,079 - $12,932	-100 Reduced 2.77%	3,512 $389,000
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $58,437 - $68,785	-525 Reduced 12.69%	3,612 $469,000
Q4 2018 Jan 24, 2019	SELL	$105.9 - $118.64 $90,650 - $101,555	-856 Reduced 17.14%	4,137 $478,000
Q3 2018 Oct 15, 2018	SELL	$85.86 - $107.31 $18,202 - $22,749	-212 Reduced 4.07%	4,993 $537,000
Q2 2018 Jul 30, 2018	SELL	$75.7 - $86.88 $15,140 - $17,376	-200 Reduced 3.7%	5,205 $444,000
Q1 2018 Apr 24, 2018	SELL	$74.21 - $87.6 $63,523 - $74,985	-856 Reduced 13.67%	5,405 $418,000
Q4 2017 Feb 02, 2018	BUY	$81.94 - $87.89 $513,026 - $550,279	6,261	6,261 $529,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Puzo Michael J, based on Form 13F filings with the SEC.

News

Stay updated on Puzo Michael J with notifications on news.

Account